Works matching AU Garcia-Manero, Guillermo


Results: 563
    1

    Long-term results of frontline dasatinib in chronic myeloid leukemia.

    Published in:
    2020
    By:
    • Maiti, Abhishek;
    • Cortes, Jorge E.;
    • Patel, Keyur P.;
    • Masarova, Lucia;
    • Borthakur, Gautam;
    • Ravandi, Farhad;
    • Verstovsek, Srdan;
    • Ferrajoli, Alessandra;
    • Estrov, Zeev;
    • Garcia‐Manero, Guillermo;
    • Kadia, Tapan M.;
    • Nogueras‐González, Graciela M.;
    • Skinner, Jeffrey;
    • Poku, Rebecca;
    • DellaSala, Sara;
    • Luthra, Rajyalakshmi;
    • Jabbour, Elias J.;
    • O'Brien, Susan;
    • Kantarjian, Hagop M.;
    • Garcia-Manero, Guillermo
    Publication type:
    journal article
    2

    Long-term results of a phase 2 trial of nilotinib 400 mg twice daily in newly diagnosed patients with chronic-phase chronic myeloid leukemia.

    Published in:
    2020
    By:
    • Masarova, Lucia;
    • Cortes, Jorge E.;
    • Patel, Keyur P.;
    • O'Brien, Susan;
    • Nogueras‐Gonzalez, Graciela M.;
    • Konopleva, Marina;
    • Verstovsek, Srdan;
    • Garcia‐Manero, Guillermo;
    • Ferrajoli, Alessandra;
    • Kadia, Tapan M.;
    • Ravandi‐Kashani, Farhad;
    • Borthakur, Gautam;
    • DellaSala, Sara;
    • Estrov, Zeev;
    • Jabbour, Elias J.;
    • Kantarjian, Hagop M.;
    • Nogueras-Gonzalez, Graciela M;
    • Garcia-Manero, Guillermo;
    • Ravandi-Kashani, Farhad
    Publication type:
    journal article
    3

    Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia.

    Published in:
    2020
    By:
    • Sasaki, Koji;
    • Kanagal‐Shamanna, Rashmi;
    • Montalban‐Bravo, Guillermo;
    • Assi, Rita;
    • Jabbour, Elias;
    • Ravandi, Farhad;
    • Kadia, Tapan;
    • Pierce, Sherry;
    • Takahashi, Koichi;
    • Nogueras Gonzalez, Graciela;
    • Patel, Keyur;
    • Soltysiak, Kelly A.;
    • Cortes, Jorge;
    • Kantarjian, Hagop M.;
    • Garcia‐Manero, Guillermo;
    • Kanagal-Shamanna, Rashmi;
    • Montalban-Bravo, Guillermo;
    • Garcia-Manero, Guillermo
    Publication type:
    journal article
    4

    Sorafenib plus intensive chemotherapy improves survival in patients with newly diagnosed, FLT3-internal tandem duplication mutation-positive acute myeloid leukemia.

    Published in:
    2019
    By:
    • Sasaki, Koji;
    • Kantarjian, Hagop M.;
    • Kadia, Tapan;
    • Patel, Keyur;
    • Loghavi, Sanam;
    • Garcia‐Manero, Guillermo;
    • Jabbour, Elias J.;
    • DiNardo, Courtney;
    • Pemmaraju, Naveen;
    • Daver, Naval;
    • Dalle, Iman Abou;
    • Short, Nicholas;
    • Yilmaz, Musa;
    • Bose, Prithviraj;
    • Naqvi, Kiran;
    • Pierce, Sherry;
    • Yalniz, Fevzi;
    • Cortes, Jorge E.;
    • Ravandi, Farhad;
    • Garcia-Manero, Guillermo
    Publication type:
    journal article
    5
    6

    Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemia.

    Published in:
    2019
    By:
    • Benton, Christopher B.;
    • Boddu, Prajwal C.;
    • DiNardo, Courtney D.;
    • Bose, Prithviraj;
    • Wang, Feng;
    • Assi, Rita;
    • Pemmaraju, Naveen;
    • KC, Devendra;
    • Pierce, Sherry;
    • Patel, Keyur;
    • Konopleva, Marina;
    • Ravandi, Farhad;
    • Garcia‐Manero, Guillermo;
    • Kadia, Tapan M.;
    • Cortes, Jorge;
    • Kantarjian, Hagop M.;
    • Andreeff, Michael;
    • Verstovsek, Srdan;
    • Garcia-Manero, Guillermo
    Publication type:
    journal article
    7
    8

    Validation of the 2017 European LeukemiaNet classification for acute myeloid leukemia with NPM1 and FLT3-internal tandem duplication genotypes.

    Published in:
    2019
    By:
    • Boddu, Prajwal C.;
    • Kadia, Tapan M.;
    • Garcia‐Manero, Guillermo;
    • Cortes, Jorge;
    • Alfayez, Mansour;
    • Borthakur, Gautam;
    • Konopleva, Marina;
    • Jabbour, Elias J.;
    • Daver, Naval G.;
    • DiNardo, Courtney D.;
    • Naqvi, Kiran;
    • Yilmaz, Musa;
    • Short, Nicholas J.;
    • Pierce, Sherry;
    • Kantarjian, Hagop M.;
    • Ravandi, Farhad;
    • Garcia-Manero, Guillermo;
    • Kantarjian, Hagop
    Publication type:
    journal article
    9
    10
    11

    Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.

    Published in:
    2018
    By:
    • DiNardo, Courtney D.;
    • Routbort, Mark J.;
    • Bannon, Sarah A.;
    • Benton, Christopher B.;
    • Takahashi, Koichi;
    • Kornblau, Steve M.;
    • Luthra, Rajyalakshmi;
    • Kanagal‐Shamanna, Rashmi;
    • Medeiros, L. Jeffrey;
    • Garcia‐Manero, Guillermo;
    • M. Kantarjian, Hagop;
    • Futreal, P. Andrew;
    • Meric‐Bernstam, Funda;
    • Patel, Keyur P.;
    • Kanagal-Shamanna, Rashmi;
    • Garcia-Manero, Guillermo;
    • Meric-Bernstam, Funda
    Publication type:
    journal article
    12
    13
    14
    15

    Persistence of minimal residual disease assessed by multiparameter flow cytometry is highly prognostic in younger patients with acute myeloid leukemia.

    Published in:
    2017
    By:
    • Ravandi, Farhad;
    • Jorgensen, Jeffrey;
    • Borthakur, Gautam;
    • Jabbour, Elias;
    • Kadia, Tapan;
    • Pierce, Sherry;
    • Brandt, Mark;
    • Wang, Sa;
    • Konoplev, Sergej;
    • Wang, Xuemei;
    • Huang, Xuelin;
    • Daver, Naval;
    • DiNardo, Courtney;
    • Andreeff, Michael;
    • Konopleva, Marina;
    • Estrov, Zeev;
    • Garcia‐Manero, Guillermo;
    • Cortes, Jorge;
    • Kantarjian, Hagop;
    • Garcia-Manero, Guillermo
    Publication type:
    journal article
    16

    Hyper-CVAD plus ponatinib versus hyper-CVAD plus dasatinib as frontline therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A propensity score analysis.

    Published in:
    2016
    By:
    • Sasaki, Koji;
    • Jabbour, Elias J.;
    • Ravandi, Farhad;
    • Short, Nicholas J.;
    • Thomas, Deborah A.;
    • Garcia‐Manero, Guillermo;
    • Daver, Naval G.;
    • Kadia, Tapan M.;
    • Konopleva, Marina Y.;
    • Jain, Nitin;
    • Issa, Ghayas C.;
    • Jeanis, Vicki;
    • Moore, Haim G.;
    • Garris, Rebecca S.;
    • Pemmaraju, Naveen;
    • Cortes, Jorge E.;
    • O'Brien, Susan M.;
    • Kantarjian, Hagop M.;
    • Garcia-Manero, Guillermo
    Publication type:
    journal article
    17
    18
    19

    Diagnostic and molecular testing patterns in patients with newly diagnosed acutemyeloid leukemia in the Connect® MDS/AML Disease Registry.

    Published in:
    EJHaem, 2020, v. 1, n. 1, p. 1, doi. 10.1002/jha2.16
    By:
    • Pollyea, Daniel A.;
    • George, Tracy I.;
    • Abedi, Mehrdad;
    • Bejar, Rafael;
    • Cogle, Christopher R.;
    • Foucar, Kathryn;
    • Garcia-Manero, Guillermo;
    • Grinblatt, David L.;
    • Komrokji, Rami S.;
    • Maciejewski, Jaroslaw P.;
    • Revicki, Dennis A.;
    • Roboz, Gail J.;
    • Savona, Michael R.;
    • Scott, Bart L.;
    • Sekeres, Mikkael A.;
    • Thompson, Michael A.;
    • Kurtin, Sandra E.;
    • Louis, Chrystal U.;
    • Nifenecker, Melissa;
    • Flick, E. Dawn
    Publication type:
    Article
    20

    Health-Related Quality of Life Outcomes in Patients with Myelodysplastic Syndromes with Ring Sideroblasts Treated with Luspatercept in the MEDALIST Phase 3 Trial.

    Published in:
    Journal of Clinical Medicine, 2022, v. 11, n. 1, p. 27, doi. 10.3390/jcm11010027
    By:
    • Oliva, Esther Natalie;
    • Platzbecker, Uwe;
    • Garcia-Manero, Guillermo;
    • Mufti, Ghulam J.;
    • Santini, Valeria;
    • Sekeres, Mikkael A.;
    • Komrokji, Rami S.;
    • Shetty, Jeevan K.;
    • Tang, Derek;
    • Guo, Shien;
    • Liao, Weiqin;
    • Zhang, George;
    • Ha, Xianwei;
    • Ito, Rodrigo;
    • Lord-Bessen, Jennifer;
    • Backstrom, Jay T.;
    • Fenaux, Pierre
    Publication type:
    Article
    21
    22

    Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of concept.

    Published in:
    Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1249511
    By:
    • Aminu, Muhammad;
    • Daver, Naval;
    • Godoy, Myrna C. B.;
    • Shroff, Girish;
    • Wu, Carol;
    • Torre-Sada, Luis F.;
    • Goizueta, Alberto;
    • Shannon, Vickie R.;
    • Faiz, Saadia A.;
    • Altan, Mehmet;
    • Garcia-Manero, Guillermo;
    • Kantarjian, Hagop;
    • Ravandi-Kashani, Farhad;
    • Kadia, Tapan;
    • Konopleva, Marina;
    • DiNardo, Courtney;
    • Pierce, Sherry;
    • Aung Naing;
    • Kim, Sang T.;
    • Kontoyiannis, Dimitrios P.
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30

    Integration of Optical Genome Mapping in the Cytogenomic and Molecular Work‐Up of Hematological Malignancies: Expert Recommendations From the International Consortium for Optical Genome Mapping.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 6, p. 1029, doi. 10.1002/ajh.27688
    By:
    • Kanagal‐Shamanna, Rashmi;
    • Puiggros, Anna;
    • Granada, Isabel;
    • Raca, Gordana;
    • Rack, Katrina;
    • Mallo, Mar;
    • Dewaele, Barbara;
    • Smith, Adam C.;
    • Akkari, Yassmine;
    • Levy, Brynn;
    • Hasserjian, Robert P.;
    • Cisneros, Adela;
    • Salido, Marta;
    • Garcia‐Manero, Guillermo;
    • Yang, Hui;
    • Iqbal, M. Anwar;
    • Kolhe, Ravindra;
    • Solé, Francesc;
    • Espinet, Blanca
    Publication type:
    Article
    31

    Clinico‐Genomic Interrogation of Secondary‐Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary Therapies.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 5, p. 758, doi. 10.1002/ajh.27628
    By:
    • Senapati, Jayastu;
    • Loghavi, Sanam;
    • Marvin‐Peek, Jennifer;
    • Garcia‐Manero, Guillermo;
    • Kadia, Tapan M.;
    • Borthakur, Gautam;
    • Daver, Naval;
    • Short, Nicholas J.;
    • Jain, Nitin;
    • Issa, Ghayas C.;
    • Haddad, Fadi;
    • Hammond, Danielle;
    • Chien, Kelly;
    • Tang, Guillin;
    • Thakral, Beenu;
    • Montalban‐Bravo, Guillermo;
    • Pemmaraju, Naveen;
    • Bazinet, Alexandre;
    • Swaminathan, Mahesh;
    • Pierce, Sherry
    Publication type:
    Article
    32

    Prospective Pharmacokinetic Evaluation of Venetoclax in AML Supports Re‐Evaluation of Recommended Dose Adjustments With Azole Antifungals.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 4, p. 740, doi. 10.1002/ajh.27613
    By:
    • Kawedia, Jitesh D.;
    • Rausch, Caitlin R.;
    • Liu, Xiaoqian;
    • Qiao, Wei;
    • Dinardo, Courtney D.;
    • Daver, Naval;
    • Borthakur, Gautam;
    • Pemmaraju, Naveen;
    • Reville, Patrick;
    • Kontoyiannis, Dimitrios P.;
    • Short, Nicholas;
    • Konopleva, Marina;
    • Jabbour, Elias;
    • Garcia‐Manero, Guillermo;
    • Ravandi, Farhad;
    • Kantarjian, Hagop;
    • Kadia, Tapan M.
    Publication type:
    Article
    33

    Outcomes of Patients With Treated Secondary Acute Myeloid Leukemia: A High‐Risk Subtype That Warrants an Independent Prognostic Designation.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 2, p. 249, doi. 10.1002/ajh.27561
    By:
    • Senapati, Jayastu;
    • Kantarjian, Hagop M.;
    • Haddad, Fadi G.;
    • Short, Nicholas J.;
    • Borthakur, Gautam;
    • Kanagal‐Shamanna, Rashmi;
    • Tang, Guilin;
    • Jabbour, Elias;
    • DiNardo, Courtney D.;
    • Daver, Naval;
    • Montalban‐Bravo, Guillermo;
    • Shah, Vishrut;
    • Alousi, Amin;
    • Shpall, Elizabeth;
    • Popat, Uday;
    • Garcia‐Manero, Guillermo;
    • Ravandi, Farhad;
    • Kadia, Tapan M.
    Publication type:
    Article
    34
    35

    Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 7, p. 1434, doi. 10.1002/ajh.27333
    By:
    • Abuasab, Tareq;
    • Borthakur, Gautam;
    • Kanagal‐Shamanna, Rashmi;
    • Masarova, Lucia;
    • Patel, Keyur;
    • Takahashi, Koichi;
    • Bose, Prithviraj;
    • Villarreal, John;
    • Pierce, Sherry;
    • Kadia, Tapan;
    • Garcia‐Manero, Guillermo;
    • Short, Nicholas J.;
    • DiNardo, Courtney;
    • Daver, Naval;
    • Ravandi, Farhad;
    • Kantarjian, Hagop;
    • Verstovsek, Srdan;
    • Yilmaz, Musa
    Publication type:
    Article
    36

    Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 4, p. 792, doi. 10.1002/ajh.27236
    By:
    • Bataller, Alex;
    • DiNardo, Courtney D.;
    • Bazinet, Alexandre;
    • Daver, Naval G.;
    • Maiti, Abhishek;
    • Borthakur, Gautam;
    • Short, Nicholas;
    • Sasaki, Koji;
    • Jabbour, Elias J.;
    • Issa, Ghayas C.;
    • Pemmaraju, Naveen;
    • Yilmaz, Musa;
    • Montalban‐Bravo, Guillermo;
    • Loghavi, Sanam;
    • Garcia‐Manero, Guillermo;
    • Ravandi, Farhad;
    • Kantarjian, Hagop M.;
    • Kadia, Tapan M.
    Publication type:
    Article
    37

    Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM‐3 antibody, in combination with decitabine or azacitidine in high‐ or very high‐risk myelodysplastic syndromes.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 2, p. E32, doi. 10.1002/ajh.27161
    By:
    • Brunner, Andrew M.;
    • Esteve, Jordi;
    • Porkka, Kimmo;
    • Knapper, Steve;
    • Traer, Elie;
    • Scholl, Sebastian;
    • Garcia‐Manero, Guillermo;
    • Vey, Norbert;
    • Wermke, Martin;
    • Janssen, Jeroen J. W. M.;
    • Narayan, Rupa;
    • Fleming, Shaun;
    • Loo, Sun;
    • Tovar, Natalia;
    • Kontro, Mika;
    • Ottmann, Oliver G.;
    • Naidu, Purushotham;
    • Sun, Haiying;
    • Han, May;
    • White, Roisin
    Publication type:
    Article
    38

    Performance of IPSS‐M in patients with myelodysplastic syndrome after hypomethylating agent failure.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 10, p. E281, doi. 10.1002/ajh.27043
    By:
    • Urrutia, Samuel;
    • Chien, Kelly S.;
    • Li, Ziyi;
    • Bataller, Alex;
    • Almanza, Emmanuel;
    • Sasaki, Koji;
    • Montalban‐Bravo, Guillermo;
    • Short, Nicholas J.;
    • Jabbour, Elias;
    • Kadia, Tapan M.;
    • Ravandi, Farhad;
    • Borthakur, Gautam;
    • Alvarado, Yesid;
    • Daver, Naval;
    • Kanagal‐Shamanna, Rashmi;
    • Bueso‐Ramos, Carlos;
    • Pierce, Sherry A.;
    • Kantarjian, Hagop;
    • Garcia‐Manero, Guillermo
    Publication type:
    Article
    39

    Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantation.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 9, p. 1383, doi. 10.1002/ajh.26997
    By:
    • Bazinet, Alexandre;
    • Kantarjian, Hagop;
    • Arani, Naszrin;
    • Popat, Uday;
    • Bataller, Alex;
    • Sasaki, Koji;
    • DiNardo, Courtney D.;
    • Daver, Naval;
    • Yilmaz, Musa;
    • Abbas, Hussein A.;
    • Short, Nicholas J.;
    • Issa, Ghayas;
    • Jabbour, Elias;
    • Pierce, Sherry A.;
    • Chen, Julianne;
    • Garcia, Ricky;
    • Konopleva, Marina;
    • Garcia‐Manero, Guillermo;
    • Alousi, Amin;
    • Shpall, Elizabeth J.
    Publication type:
    Article
    40
    41

    Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 4, p. E91, doi. 10.1002/ajh.26858
    By:
    • Siddiqui, Maria;
    • Konoplev, Sergej;
    • Issa, Ghayas;
    • Kantarjian, Hagop;
    • Daver, Naval;
    • Ravandi, Farhad;
    • Kadia, Tapan;
    • Tang, Guilin;
    • Wang, Sa A.;
    • Thakral, Beenu;
    • Medeiros, L. Jeffrey;
    • Pozdnyakova, Olga;
    • Pierce, Sherry;
    • Montalban‐Bravo, Guillermo;
    • Chien, Kelly;
    • Hammond, Danielle;
    • Sasaki, Koji;
    • Garcia‐Manero, Guillermo;
    • Hasserjian, Robert P.
    Publication type:
    Article
    42

    The outcomes of patients with chronic myeloid leukemia treated with third‐line BCR::ABL1 tyrosine kinase inhibitors.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 4, p. 658, doi. 10.1002/ajh.26852
    By:
    • Jabbour, Elias J.;
    • Sasaki, Koji;
    • Haddad, Fadi G.;
    • Issa, Ghayas C.;
    • Garcia‐Manero, Guillermo;
    • Kadia, Tapan M.;
    • Jain, Nitin;
    • Yilmaz, Musa;
    • DiNardo, Courtney D.;
    • Patel, Keyur P.;
    • Kanagal‐Shamanna, Rashmi;
    • Champlin, Richard;
    • Khouri, Issa F.;
    • Dellasala, Sara;
    • Pierce, Sherry A.;
    • Kantarjian, Hagop
    Publication type:
    Article
    43

    Frontline combination of ponatinib and hyper‐CVAD in Philadelphia chromosome‐positive acute lymphoblastic leukemia: 80‐months follow‐up results.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 3, p. 493, doi. 10.1002/ajh.26816
    By:
    • Kantarjian, Hagop;
    • Short, Nicholas J.;
    • Jain, Nitin;
    • Sasaki, Koji;
    • Huang, Xuelin;
    • Haddad, Fadi G.;
    • Khouri, Issa;
    • DiNardo, Courtney D.;
    • Pemmaraju, Naveen;
    • Wierda, William;
    • Garcia‐Manero, Guillermo;
    • Kebriaei, Partow;
    • Garris, Rebecca;
    • Loghavi, Sanam;
    • Jorgensen, Jeffrey;
    • Kwari, Monica;
    • O'Brien, Susan;
    • Ravandi, Farhad;
    • Jabbour, Elias
    Publication type:
    Article
    44

    A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 2, p. 272, doi. 10.1002/ajh.26771
    By:
    • Zeidan, Amer M.;
    • Borate, Uma;
    • Pollyea, Daniel A.;
    • Brunner, Andrew M.;
    • Roncolato, Fernando;
    • Garcia, Jacqueline S.;
    • Filshie, Robin;
    • Odenike, Olatoyosi;
    • Watson, Anne Marie;
    • Krishnadasan, Ravitharan;
    • Bajel, Ashish;
    • Naqvi, Kiran;
    • Zha, Jiuhong;
    • Cheng, Wei‐Han;
    • Zhou, Ying;
    • Hoffman, David;
    • Harb, Jason G.;
    • Potluri, Jalaja;
    • Garcia‐Manero, Guillermo
    Publication type:
    Article
    45

    Intrathecal prophylaxis with 12 versus 8 administrations reduces the incidence of central nervous system relapse in patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 1, p. E11, doi. 10.1002/ajh.26622
    By:
    • Paul, Shilpa;
    • Kantarjian, Hagop;
    • Sasaki, Koji;
    • Marx, Kayleigh;
    • Jain, Nitin;
    • Savoy, J. Michael;
    • DiPippo, Adam;
    • Jammal, Nadya;
    • Bravo, Guillermo Montalban;
    • Kadia, Tapan;
    • Garcia‐Manero, Guillermo;
    • Short, Nicholas J.;
    • Ravandi, Farhad;
    • Jabbour, Elias
    Publication type:
    Article
    46

    Implications of RAS mutational status in subsets of patients with newly diagnosed acute myeloid leukemia across therapy subtypes.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 12, p. 1599, doi. 10.1002/ajh.26731
    By:
    • Rivera, Daniel;
    • Kim, Kunhwa;
    • Kanagal‐Shamanna, Rashmi;
    • Borthakur, Gautam;
    • Montalban‐Bravo, Guillermo;
    • Daver, Naval;
    • Dinardo, Courtney;
    • Short, Nicholas J.;
    • Yilmaz, Musa;
    • Pemmaraju, Naveen;
    • Takahashi, Koichi;
    • Jabbour, Elias J.;
    • Pierce, Sherry;
    • Konopleva, Marina;
    • Bhalla, Kapil;
    • Garcia‐Manero, Guillermo;
    • Ravandi, Farhad;
    • Kantarjian, Hagop;
    • Kadia, Tapan M.
    Publication type:
    Article
    47

    Retrospective comparison of survival and responses to Fludarabine, Cytarabine, GCSF (FLAG) in combination with gemtuzumab ozogamicin (GO) or Idarubicin (IDA) in patients with newly diagnosed core binding factor (CBF) acute myelogenous leukemia: MD Anderson experience in 174 patients

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 11, p. 1427, doi. 10.1002/ajh.26700
    By:
    • Borthakur, Gautam;
    • Ravandi, Farhad;
    • Patel, Keyur;
    • Wang, Xuemei;
    • Kadia, Tapan;
    • DiNardo, Courtney;
    • Garcia‐Manero, Guillermo;
    • Pemmaraju, Naveen;
    • Jabbour, Elias J.;
    • Takahashi, Koichi;
    • Ohanian, Maro;
    • Daver, Naval;
    • Alvarado, Yesid;
    • Brandt, Mark;
    • Pierce, Sherry;
    • Kantarjian, Hagop
    Publication type:
    Article
    48

    Low‐dose dasatinib 50 mg/day versus standard‐dose dasatinib 100 mg/day as frontline therapy in chronic myeloid leukemia in chronic phase: A propensity score analysis.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 11, p. 1413, doi. 10.1002/ajh.26689
    By:
    • Jabbour, Elias;
    • Sasaki, Koji;
    • Haddad, Fadi G.;
    • Issa, Ghayas C.;
    • Skinner, Jeffrey;
    • Dellasala, Sara;
    • Yilmaz, Musa;
    • Ferrajoli, Alessandra;
    • Bose, Prithviraj;
    • Thompson, Philip;
    • Alvarado, Yesid;
    • Jain, Nitin;
    • Garcia‐Manero, Guillermo;
    • Takahashi, Koichi;
    • Borthakur, Gautam;
    • Pemmaraju, Naveen;
    • Pierce, Sherry;
    • Kantarjian, Hagop
    Publication type:
    Article
    49
    50

    Blinatumomab is associated with favorable outcomes in patients with B‐cell lineage acute lymphoblastic leukemia and positive measurable residual disease at a threshold of 10<sup>−4</sup> and higher.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 9, p. 1135, doi. 10.1002/ajh.26634
    By:
    • Jabbour, Elias J.;
    • Short, Nicholas J.;
    • Jain, Nitin;
    • Jammal, Nadya;
    • Jorgensen, Jeffrey;
    • Wang, Sa;
    • Wang, Xuemei;
    • Ohanian, Maro;
    • Alvarado, Yesid;
    • Kadia, Tapan;
    • Sasaki, Koji;
    • Garris, Rebecca;
    • Garcia‐Manero, Guillermo;
    • Ravandi, Farhad;
    • Kantarjian, Hagop M.
    Publication type:
    Article